Xeris Biopharma Holdings, Inc. XERS Current ratio

Current ratio at other companies

Eli LillyLLY

1.4×+0.1×

Corcept TherapeuticsCORT

2.9×-0.2×

Eton Pharmaceuticals, Inc.ETON

1.2×-0.8×

Zevra Therapeutics, Inc.ZVRA

5.2×-2.7×

Ultragenyx PharmaceuticalRARE

1.7×-0.7×

ANI PharmaceuticalsANIP

2.9×+0.4×

FAQ

What is Xeris Biopharma Holdings, Inc.'s current ratio?

Xeris Biopharma Holdings, Inc. (XERS) reported current ratio of 1.4× in Q2 2026.

How has Xeris Biopharma Holdings, Inc.'s current ratio changed year-over-year?

Xeris Biopharma Holdings, Inc.'s current ratio decreased by 25.7% year-over-year, from 1.9× to 1.4×.

What is the long-term trend for Xeris Biopharma Holdings, Inc.'s current ratio?

Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s current ratio has grown at a -16.5% compound annual growth rate (CAGR), from 5.4× to 2.2×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.